REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,785,000 | +455.9% | 85,000 | +347.4% | 0.08% | +680.0% |
| Q4 2021 | $501,000 | -41.0% | 19,000 | +216.7% | 0.01% | -66.7% |
| Q2 2021 | $849,000 | -14.8% | 6,000 | -40.0% | 0.03% | +20.0% |
| Q1 2021 | $997,000 | +582.9% | 10,000 | +566.7% | 0.02% | +400.0% |
| Q3 2020 | $146,000 | -92.5% | 1,500 | -88.0% | 0.01% | -96.3% |
| Q2 2020 | $1,950,000 | +138.4% | 12,500 | +212.5% | 0.14% | +164.7% |
| Q4 2019 | $818,000 | +581.7% | 4,000 | +166.7% | 0.05% | +363.6% |
| Q3 2019 | $120,000 | -15.5% | 1,500 | 0.0% | 0.01% | -31.2% |
| Q2 2019 | $142,000 | +10.9% | 1,500 | 0.0% | 0.02% | +23.1% |
| Q1 2019 | $128,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |